CN1074905A - 吡咯基苯并二氮杂酮 - Google Patents

吡咯基苯并二氮杂酮 Download PDF

Info

Publication number
CN1074905A
CN1074905A CN93100812A CN93100812A CN1074905A CN 1074905 A CN1074905 A CN 1074905A CN 93100812 A CN93100812 A CN 93100812A CN 93100812 A CN93100812 A CN 93100812A CN 1074905 A CN1074905 A CN 1074905A
Authority
CN
China
Prior art keywords
compound
dihydro
pyrrol
product
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN93100812A
Other languages
English (en)
Chinese (zh)
Inventor
M-C·舒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN1074905A publication Critical patent/CN1074905A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN93100812A 1992-01-24 1993-01-20 吡咯基苯并二氮杂酮 Pending CN1074905A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82547592A 1992-01-24 1992-01-24
US825,475 1992-01-24

Publications (1)

Publication Number Publication Date
CN1074905A true CN1074905A (zh) 1993-08-04

Family

ID=25244088

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93100812A Pending CN1074905A (zh) 1992-01-24 1993-01-20 吡咯基苯并二氮杂酮

Country Status (16)

Country Link
EP (1) EP0552665A1 (cg-RX-API-DMAC10.html)
JP (1) JPH069623A (cg-RX-API-DMAC10.html)
KR (1) KR930016417A (cg-RX-API-DMAC10.html)
CN (1) CN1074905A (cg-RX-API-DMAC10.html)
AU (1) AU3185693A (cg-RX-API-DMAC10.html)
BR (1) BR9300250A (cg-RX-API-DMAC10.html)
CA (1) CA2086368A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ372792A3 (cg-RX-API-DMAC10.html)
FI (1) FI930244A7 (cg-RX-API-DMAC10.html)
HU (1) HUT63162A (cg-RX-API-DMAC10.html)
IL (1) IL104424A0 (cg-RX-API-DMAC10.html)
MX (1) MX9300260A (cg-RX-API-DMAC10.html)
NO (1) NO930224L (cg-RX-API-DMAC10.html)
TW (1) TW221687B (cg-RX-API-DMAC10.html)
UY (1) UY23540A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA93285B (cg-RX-API-DMAC10.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106831726A (zh) * 2017-01-22 2017-06-13 苏州楚凯药业有限公司 抗病毒药物中间体苯并二氮杂酮衍生物的制备方法
CN107056760A (zh) * 2017-01-22 2017-08-18 苏州楚凯药业有限公司 5,7位取代的1H‑苯并[e][1,4]二氮杂‑2(3H)‑酮衍生物的制备方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250410B2 (en) 2001-06-07 2007-07-31 Via Pharmaceuticals, Inc. Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
JP4197965B2 (ja) 2003-01-31 2008-12-17 オリンパス株式会社 高周波スネアと医療器具
KR20200144870A (ko) 2019-06-19 2020-12-30 김상은 항곰팡이 및 항균성이 우수한 수지 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL96133A0 (en) * 1989-10-30 1991-07-18 Hoffmann La Roche Antiviral pharmaceutical compositions containing a benzodiazepine and a phenylpyrrylketone derivative
EP0475231A1 (en) * 1990-09-10 1992-03-18 F. Hoffmann-La Roche Ag Benzodiazepines
EP0491218A1 (en) * 1990-12-17 1992-06-24 F. Hoffmann-La Roche Ag Benzodiazepinones

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106831726A (zh) * 2017-01-22 2017-06-13 苏州楚凯药业有限公司 抗病毒药物中间体苯并二氮杂酮衍生物的制备方法
CN107056760A (zh) * 2017-01-22 2017-08-18 苏州楚凯药业有限公司 5,7位取代的1H‑苯并[e][1,4]二氮杂‑2(3H)‑酮衍生物的制备方法

Also Published As

Publication number Publication date
CA2086368A1 (en) 1993-07-25
JPH069623A (ja) 1994-01-18
MX9300260A (es) 1993-07-01
HU9300117D0 (en) 1993-04-28
BR9300250A (pt) 1993-07-27
HUT63162A (en) 1993-07-28
KR930016417A (ko) 1993-08-26
FI930244L (fi) 1993-07-25
NO930224D0 (no) 1993-01-22
AU3185693A (en) 1993-07-29
CZ372792A3 (en) 1993-12-15
EP0552665A1 (en) 1993-07-28
IL104424A0 (en) 1993-05-13
NO930224L (no) 1993-07-26
ZA93285B (en) 1993-08-19
FI930244A7 (fi) 1993-07-25
FI930244A0 (fi) 1993-01-21
TW221687B (cg-RX-API-DMAC10.html) 1994-03-11
UY23540A1 (es) 1993-07-16

Similar Documents

Publication Publication Date Title
JP3442773B2 (ja) 抗ウイルス性ヌクレオシドコンビネーション
CN1219168A (zh) 作为tnf抑制剂和pdc-iv抑制剂的喹啉磺酰胺类化合物
CN1311675A (zh) 具有lgE影响性能的化合物
CN1671727A (zh) 抗病毒7－脱氮－d－核苷及其用途
WO2020221006A1 (zh) 一种bet蛋白抑制剂、其制备方法及用途
WO2019020070A1 (zh) 哌嗪并杂芳基类衍生物、其制备方法及其在医药上的应用
CN1303378A (zh) 3－(氨基－或氨基烷基)吡啶酮衍生物和它们在hiv相关疾病治疗中的用途
EA031222B1 (ru) Бициклически замещённые урацилы и их применение
CN1062528A (zh) 苯并二氮杂酮
JP2009530401A5 (cg-RX-API-DMAC10.html)
TW201306839A (zh) 治療ｈｃｖ感染之組合療法
JP2025533641A (ja) 抗ＳＡＲＳ－ＣｏＶ－２剤の結晶形態
CN1344268A (zh) 咪唑[1,5－a]吡啶并[3,2－e]吡嗪酮作为药物的应用
CN1073936A (zh) α-取代的苯甲胺衍生物
JP2017521455A (ja) 抗ＨＩＶ作用を有するフェニル及びｔｅｒｔ−ブチル酢酸置換ピリジノン
CN1074905A (zh) 吡咯基苯并二氮杂酮
JP2008520674A (ja) Ｈｃｖインヒビター
CN1849117A (zh) Hiv病毒的侵入抑制剂
CN1081442A (zh) 苯并二氮杂䓬
CN1023560C (zh) (一)-1β-乙基-1α-羟甲基-1，2，3，4，6，7，12，12ba-八氢吲哚基[2，3-a]喹嗪的制备方法
JP2008546839A (ja) 非ヌクレオシド逆転写酵素阻害剤
JP2025533996A (ja) シアノ置換含有ポリペプチド系化合物の結晶及びその製造方法
CA2518766C (en) Anti-hepatitis c virus agents and anti-hiv agents
CN1073942A (zh) 杂环取代的苯甲胺衍生物
JP2008546712A (ja) ラクタム含有ｈｃｖ感染阻害剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication